Cargando…

Robust metrics for assessing the performance of different verbal autopsy cause assignment methods in validation studies

BACKGROUND: Verbal autopsy (VA) is an important method for obtaining cause of death information in settings without vital registration and medical certification of causes of death. An array of methods, including physician review and computer-automated methods, have been proposed and used. Choosing t...

Descripción completa

Detalles Bibliográficos
Autores principales: Murray, Christopher JL, Lozano, Rafael, Flaxman, Abraham D, Vahdatpour, Alireza, Lopez, Alan D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3160921/
https://www.ncbi.nlm.nih.gov/pubmed/21816106
http://dx.doi.org/10.1186/1478-7954-9-28
_version_ 1782210606141538304
author Murray, Christopher JL
Lozano, Rafael
Flaxman, Abraham D
Vahdatpour, Alireza
Lopez, Alan D
author_facet Murray, Christopher JL
Lozano, Rafael
Flaxman, Abraham D
Vahdatpour, Alireza
Lopez, Alan D
author_sort Murray, Christopher JL
collection PubMed
description BACKGROUND: Verbal autopsy (VA) is an important method for obtaining cause of death information in settings without vital registration and medical certification of causes of death. An array of methods, including physician review and computer-automated methods, have been proposed and used. Choosing the best method for VA requires the appropriate metrics for assessing performance. Currently used metrics such as sensitivity, specificity, and cause-specific mortality fraction (CSMF) errors do not provide a robust basis for comparison. METHODS: We use simple simulations of populations with three causes of death to demonstrate that most metrics used in VA validation studies are extremely sensitive to the CSMF composition of the test dataset. Simulations also demonstrate that an inferior method can appear to have better performance than an alternative due strictly to the CSMF composition of the test set. RESULTS: VA methods need to be evaluated across a set of test datasets with widely varying CSMF compositions. We propose two metrics for assessing the performance of a proposed VA method. For assessing how well a method does at individual cause of death assignment, we recommend the average chance-corrected concordance across causes. This metric is insensitive to the CSMF composition of the test sets and corrects for the degree to which a method will get the cause correct due strictly to chance. For the evaluation of CSMF estimation, we propose CSMF accuracy. CSMF accuracy is defined as one minus the sum of all absolute CSMF errors across causes divided by the maximum total error. It is scaled from zero to one and can generalize a method's CSMF estimation capability regardless of the number of causes. Performance of a VA method for CSMF estimation by cause can be assessed by examining the relationship across test datasets between the estimated CSMF and the true CSMF. CONCLUSIONS: With an increasing range of VA methods available, it will be critical to objectively assess their performance in assigning cause of death. Chance-corrected concordance and CSMF accuracy assessed across a large number of test datasets with widely varying CSMF composition provide a robust strategy for this assessment.
format Online
Article
Text
id pubmed-3160921
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-31609212011-08-25 Robust metrics for assessing the performance of different verbal autopsy cause assignment methods in validation studies Murray, Christopher JL Lozano, Rafael Flaxman, Abraham D Vahdatpour, Alireza Lopez, Alan D Popul Health Metr Research BACKGROUND: Verbal autopsy (VA) is an important method for obtaining cause of death information in settings without vital registration and medical certification of causes of death. An array of methods, including physician review and computer-automated methods, have been proposed and used. Choosing the best method for VA requires the appropriate metrics for assessing performance. Currently used metrics such as sensitivity, specificity, and cause-specific mortality fraction (CSMF) errors do not provide a robust basis for comparison. METHODS: We use simple simulations of populations with three causes of death to demonstrate that most metrics used in VA validation studies are extremely sensitive to the CSMF composition of the test dataset. Simulations also demonstrate that an inferior method can appear to have better performance than an alternative due strictly to the CSMF composition of the test set. RESULTS: VA methods need to be evaluated across a set of test datasets with widely varying CSMF compositions. We propose two metrics for assessing the performance of a proposed VA method. For assessing how well a method does at individual cause of death assignment, we recommend the average chance-corrected concordance across causes. This metric is insensitive to the CSMF composition of the test sets and corrects for the degree to which a method will get the cause correct due strictly to chance. For the evaluation of CSMF estimation, we propose CSMF accuracy. CSMF accuracy is defined as one minus the sum of all absolute CSMF errors across causes divided by the maximum total error. It is scaled from zero to one and can generalize a method's CSMF estimation capability regardless of the number of causes. Performance of a VA method for CSMF estimation by cause can be assessed by examining the relationship across test datasets between the estimated CSMF and the true CSMF. CONCLUSIONS: With an increasing range of VA methods available, it will be critical to objectively assess their performance in assigning cause of death. Chance-corrected concordance and CSMF accuracy assessed across a large number of test datasets with widely varying CSMF composition provide a robust strategy for this assessment. BioMed Central 2011-08-04 /pmc/articles/PMC3160921/ /pubmed/21816106 http://dx.doi.org/10.1186/1478-7954-9-28 Text en Copyright ©2011 Murray et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Murray, Christopher JL
Lozano, Rafael
Flaxman, Abraham D
Vahdatpour, Alireza
Lopez, Alan D
Robust metrics for assessing the performance of different verbal autopsy cause assignment methods in validation studies
title Robust metrics for assessing the performance of different verbal autopsy cause assignment methods in validation studies
title_full Robust metrics for assessing the performance of different verbal autopsy cause assignment methods in validation studies
title_fullStr Robust metrics for assessing the performance of different verbal autopsy cause assignment methods in validation studies
title_full_unstemmed Robust metrics for assessing the performance of different verbal autopsy cause assignment methods in validation studies
title_short Robust metrics for assessing the performance of different verbal autopsy cause assignment methods in validation studies
title_sort robust metrics for assessing the performance of different verbal autopsy cause assignment methods in validation studies
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3160921/
https://www.ncbi.nlm.nih.gov/pubmed/21816106
http://dx.doi.org/10.1186/1478-7954-9-28
work_keys_str_mv AT murraychristopherjl robustmetricsforassessingtheperformanceofdifferentverbalautopsycauseassignmentmethodsinvalidationstudies
AT lozanorafael robustmetricsforassessingtheperformanceofdifferentverbalautopsycauseassignmentmethodsinvalidationstudies
AT flaxmanabrahamd robustmetricsforassessingtheperformanceofdifferentverbalautopsycauseassignmentmethodsinvalidationstudies
AT vahdatpouralireza robustmetricsforassessingtheperformanceofdifferentverbalautopsycauseassignmentmethodsinvalidationstudies
AT lopezaland robustmetricsforassessingtheperformanceofdifferentverbalautopsycauseassignmentmethodsinvalidationstudies